Immune monitoring of malignant glioma patients treated with WT1 Trio peptide-based cancer immunotherapy

被引：0
|
作者：
Kanegae, Mizuki [1 ]
Kagawa, Naoki [1 ]
Kijima, Noriyuki [2 ]
Hirayama, Ryuichi [2 ]
Shimokado, Haruka [1 ,2 ]
Nishida, Sumiyuki [3 ]
Hosen, Naoki [4 ]
Tsuboi, Akihiro [5 ]
Oka, Yoshihiro [6 ]
Sugiyama, Haruo [7 ]
Kishima, Haruhiko [8 ]
Oji, Yusuke [1 ]
机构：
[1] Osaka Univ, CLBS, Grad Sch Med, Osaka, Japan
[2] Osaka Univ, NeuroSurg, Grad Sch Med, Osaka, Japan
[3] Osaka Univ, Res Med Clin Imm, Grad Sch Med, Osaka, Japan
[4] Osaka Univ, Hematol Oncol, Grad Sch Med, Osaka, Japan
[5] Osaka Univ, Canc Immther, Grad Sch Med, Osaka, Japan
[6] Osaka Univ, Canc Stem Cell Biol, Grad Sch Med, Osaka, Japan
[7] Osaka Univ, Grad Sch Med, Osaka, Japan
[8] Osaka Univ, NeuroSurg, Grad Sch Med, Osaka, Japan
来源：
CANCER SCIENCE | 2022年 / 113卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P12-2-6
引用
收藏
页码：524 / 524
页数：1
相关论文
共 50 条
  • [41] WT1-specific T-cells in healthy donors and leukemia patients and the possibility of improved detection of the immune response using WT1 peptide-pulsed dendritic cells
    Panchenko, Julia
    Kiseleva, Vi. Toriia
    Zhogov, Vladimir
    Khripkova, Natalya
    Trakhtman, Pavel
    Starostin, Nikolay
    Maschan, Michael
    Osipova, Elena
    BONE MARROW TRANSPLANTATION, 2018, 53 : 195 - 195
  • [42] Clinical Phase II Study of WT1 Peptide Vaccination in Pediatric Leukemia Patients after Stem Cell Transplantation and Analysis of Immunological Monitoring
    Hashii, Yoshiko
    Oka, Yoshihiro
    Miyamura, Takako
    Oji, Yusuke
    Hosen, Naoki
    Tsuboi, Akihiro
    Sugiyama, Haruo
    Ozono, Keiichi
    BLOOD, 2014, 124 (21)
  • [43] Phase I Study of a Multivalent WT1 Peptide Vaccine (Galinpepimut-S) in Combination with Nivolumab in Patients with WT1-Expressing Ovarian Cancer in Second or Third Remission
    Manning-Geist, Beryl L.
    Gnjatic, Sacha
    Aghajanian, Carol
    Konner, Jason
    Kim, Sarah H.
    Sarasohn, Debra
    Soldan, Krysten
    Tew, William P.
    Sarlis, Nicholas J.
    Zamarin, Dmitriy
    Kravetz, Sara
    Laface, Ilaria
    Rasalan-Ho, Teresa
    Qi, Jingjing
    Wong, Phillip
    Sabbatini, Paul J.
    O'Cearbhaill, Roisin E.
    CANCERS, 2023, 15 (05)
  • [44] WT1 peptide vaccinations induce CD4 and CD8 T cell immune responses in patients with mesothelioma and non-small cell lung cancer
    Krug, Lee M.
    Dao, Tao
    Brown, Andrew B.
    Maslak, Peter
    Travis, William
    Bekele, Sara
    Korontsvit, Tatyana
    Zakhaleva, Victoria
    Wolchok, Jedd
    Yuan, Jianda
    Li, Hao
    Tyson, Leslie
    Scheinberg, David A.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2010, 59 (10) : 1467 - 1479
  • [45] WT1 peptide vaccinations induce CD4 and CD8 T cell immune responses in patients with mesothelioma and non-small cell lung cancer
    Lee M. Krug
    Tao Dao
    Andrew B. Brown
    Peter Maslak
    William Travis
    Sara Bekele
    Tatyana Korontsvit
    Victoria Zakhaleva
    Jedd Wolchok
    Jianda Yuan
    Hao Li
    Leslie Tyson
    David A. Scheinberg
    Cancer Immunology, Immunotherapy, 2010, 59 : 1467 - 1479
  • [46] A phase I/IIa clinical trial of immunotherapy for elderly patients with acute myeloid leukaemia using dendritic cells co-pulsed with WT1 peptide and zoledronate
    Kitawaki, Toshio
    Kadowaki, Norimitsu
    Fukunaga, Keiko
    Kasai, Yasunari
    Maekawa, Taira
    Ohmori, Katsuyuki
    Kondo, Takashige
    Maekawa, Ryuji
    Takahara, Masashi
    Nieda, Mie
    Kuzushima, Kiyotaka
    Ishikawa, Takayuki
    Uchiyama, Takashi
    BRITISH JOURNAL OF HAEMATOLOGY, 2011, 153 (06) : 796 - 799
  • [47] WT1-235 CTL epitope-specific IgM and IgG antibodies in sarcoma patients treated with WT1-235 peptide cancer vaccine
    Alzaaqi, Shouq
    Outani, Hidetatsu
    Kanegae, Mizuki
    Shimokado, Haruka
    Nishida, Sumiyuki
    Hosen, Naoki
    Tsuboi, Akihiro
    Oka, Yoshihiro
    Sugiyama, Haruo
    Oji, Yusuke
    CANCER SCIENCE, 2022, 113 : 538 - 538
  • [48] Vaccination of advanced or relapsed esophageal cancer patients with WT1 and/or MUC1 peptide-pulsed dendritic cells induces immunological and clinical responses
    Ogasawara, M.
    Ota, S.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S115 - S116
  • [49] Cellular and Humoral Immune Responses Induced by an HLA Class I-restricted Peptide Cancer Vaccine Targeting WT1 Are Associated With Favorable Clinical Outcomes in Advanced Ovarian Cancer
    Nishida, Sumiyuki
    Morimoto, Soyoko
    Oji, Yusuke
    Morita, Satoshi
    Shirakata, Toshiaki
    Enomoto, Takayuki
    Tsuboi, Akihiro
    Ueda, Yutaka
    Yoshino, Kiyoshi
    Shouq, Alzaaqi
    Kanegae, Mizuki
    Ohno, Satoshi
    Fujiki, Fumihiro
    Nakajima, Hiroko
    Nakae, Yoshiki
    Nakata, Jun
    Hosen, Naoki
    Kumanogoh, Atsushi
    Oka, Yoshihiro
    Kimura, Tadashi
    Sugiyama, Haruo
    JOURNAL OF IMMUNOTHERAPY, 2022, 45 (01) : 56 - 66
  • [50] WT1 peptide vaccination in poor risk adult AML patients induces WT1-specific immune responses: Results of a leukaemia research supported phase I clinical trial, WTPV-001
    Morris, E. C.
    Martinez-Davila, I.
    Cellerai, C.
    Chen, F.
    Moss, P.
    Khwaja, A.
    Virchis, A.
    Kottaridis, P.
    Stauss, H. J.
    BRITISH JOURNAL OF HAEMATOLOGY, 2010, 149 : 16 - 16
12345